awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41386664-AC27E125-580A-4B49-9FFF-D33839D9A8AB
Q41386664-AC27E125-580A-4B49-9FFF-D33839D9A8AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-AC27E125-580A-4B49-9FFF-D33839D9A8AB
Natalizumab discontinuation in patients with multiple sclerosis: Profiling risk and benefits at therapeutic crossroads.
P50
Q41386664-AC27E125-580A-4B49-9FFF-D33839D9A8AB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41386664-AC27E125-580A-4B49-9FFF-D33839D9A8AB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
80010b3a2d7be4b4b250900102dbb38e12bd458a
P1545
2
http://www.w3.org/2001/XMLSchema#string
P50
Pietro Annovazzi